Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Editorials |1 February 2011

Immunization 2011: Expanding Coverage, Enhancing Protection Free

Sandra Adamson Fryhofer, MD

Sandra Adamson Fryhofer, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Potential Conflicts of Interest: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-2673.
Requests for Single Reprints: Sandra Adamson Fryhofer, MD, Emory University, 1938 Peachtree Road, Suite 502, Atlanta, GA 30309.
  • From Emory University, Atlanta, GA 30309.
×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • Influenza Vaccination: Expanded Coverage, New Formulations
    • Pneumococcal Vaccine: Clarifying Revaccination Strategy
    • Human Papillomavirus Vaccine: Answers and Questions
    • Tetanus, Diphtheria, Pertussis Vaccination: A Family Affair
    • Meningococcal Vaccination: Age Clarification and Booster for Kids
    • Final Thoughts: Get Vaccinated!
      1. References
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link
This issue marks the fifth consecutive year that the Advisory Committee on Immunization Practices (ACIP) Adult Immunization Schedule has appeared in Annals of Internal Medicine(1). The Adult Immunization Schedule, endorsed by the American College of Physicians (ACP), applies to persons aged 19 years or older, whereas the immunization schedule for children and adolescents (2) applies to persons aged 18 years or younger. Because internists care for adolescents and younger adults, this discussion also highlights a few key changes in the adolescent immunization schedule (2).

Influenza Vaccination: Expanded Coverage, New Formulations

The universal influenza vaccination recommendation now applies to everyone older than 6 months. Fortunately, that expanded coverage also coincides with greater availability of the vaccine. Five companies—GlaxoSmithKline, CSL, Novartis, Medimmune, and sanofi-pasteur—now manufacture influenza vaccine. The Centers for Disease Control and Prevention project that 160 million doses of vaccine will available for the 2010–2011 flu season, meaning that more flu vaccine is available than ever before.
A high-dose formulation of the influenza vaccine, Fluzone High-Dose (sanofi-pasteur, Stillwater, Pennsylvania), is a new choice for persons aged 65 years or older. This inactivated vaccine contains 4 times more hemagglutinin per dose than the standard influenza vaccine and was designed to improve immune response. Disadvantages, however, include increases in injection-site reaction and cost (Fluzone High-Dose is almost double the price of the standard inactivated influenza vaccine).
The live attenuated nasal influenza vaccine is also an option for healthy, nonpregnant persons aged 2 through 49 years. Pregnant women are at high risk for influenza complications but should receive inactivated vaccine.

Pneumococcal Vaccine: Clarifying Revaccination Strategy

Revisions in the footnotes elucidate whether and when to revaccinate with pneumococcal vaccine. The schedule recommends 1-time revaccination after 5 years for persons younger than 65 years who have high-risk conditions (for example, chronic renal failure, the nephrotic syndrome, sickle cell disease, or splenectomy) or who are immunocompromised.
The footnotes also guide practitioners on what to do when previously vaccinated patients reach 65 years of age: These patients should receive 1-time revaccination if more than 5 years have passed since the last vaccination and the patient was younger than 65 years at the time of the primary vaccination.

Human Papillomavirus Vaccine: Answers and Questions

Human papillomavirus (HPV) types 6 and 11 cause 90% of cases of genital warts. Types 16 and 18 are linked to 70% of cases of cervical cancer and are also linked to vaginal and vulvar cancer (3). A growing body of evidence also links HPV types 16 and 18 to oropharyngeal cancer; penile cancer; and anal cancer (4, 5), which is more common in men who have sex with men, especially if they are HIV positive (6).
The HPV vaccine is a prophylactic vaccine: It is most efficacious when given before exposure to HPV virus, which usually occurs at the onset of sexual activity. Two HPV vaccines currently exist. The quadrivalent vaccine (HPV4) provides protection against HPV types 6, 11, 16, 18 and is approved by the U.S. Food and Drug Administration (FDA) for males (to prevent genital warts) and for females aged 9 through 26 years (to prevent genital warts and genital cancer and precancer). In contrast, the bivalent vaccine (HPV2) provides protection against HPV types 16 and 18, but it is FDA approved only for females through age 26 years (to prevent cervical cancer and precancer). On 17 November 2010, an FDA advisory panel recommended expanding HPV4 indications to include prevention of anal intraepithelial neoplasia in both males and females aged 9 through 26 years.
The word “females” appears in parentheses after “HPV vaccine” in the adult immunization schedule; this is also a new addition in the adolescent schedule. Although the intent of adding “females” was for clarification, this addition actually sows confusion. “Females” was added to highlight that routine vaccination is recommended only for girls and young women; the ACIP granted only a permissive recommendation for boys and young men because of concerns about cost-effectiveness. The result is that the HPV vaccine may be given to young males but is not routinely recommended.

Tetanus, Diphtheria, Pertussis Vaccination: A Family Affair

Data from the 2009 National Notifiable Diseases Surveillance System of the Centers for Disease Control and Prevention show a surge in pertussis-related deaths in infants over the past 10 years. New pertussis vaccination recommendations focus on cocooning infants and young children in a circle of familial protection, thus preventing the spread of this fatal disease through family contact. Household members are responsible for up to 83% of transmission to infants (7, 8). This phenomenon results from waning pertussis protection from childhood immunization and is the reason why a tetanus, diphtheria, pertussis (Tdap) booster for adolescents, in place of 1 tetanus and diphtheria (Td) toxoid vaccine dose, was initially instituted. Unvaccinated new mothers (and fathers) are urged to get a Tdap booster before leaving the hospital after the baby is delivered. In addition, grandparents are now encouraged to get a Tdap booster.
The 2011 schedule extends single-dose Tdap vaccination to adults aged 65 years or older who will have contact with babies. This recommendation is unusual because FDA approval for all currently available Tdap vaccines stops after age 64 years. Favorable vaccine safety and efficacy data for Tdap use in adults aged 65 years or older was presented at the October 2010 ACIP meeting, and these data have been submitted to the FDA.
The new Tdap recommendation also simplifies administration by removing the barrier of an interval between Tdap vaccination and last Td vaccination. The recommendations are for direct immunization with Tdap as soon as feasible, regardless of the interval since the last tetanus- or diphtheria-containing vaccine was received. Physicians and other health care professionals should be vigilant about their own immunization to close the circle of protection—that is, they should get vaccinated with Tdap.

Meningococcal Vaccination: Age Clarification and Booster for Kids

Language revisions in the footnotes to the adult immunization schedule explain the appropriate vaccine for adults according to age: meningococcal quadrivalent vaccine (MCV4) for adults aged 55 years or younger and the meningococcal polysaccharide vaccine (MPSV4) for adults aged 56 years or older.
An important change was also made in the meningococcal adolescent vaccine program. In 2005, when the meningococcal vaccine was originally licensed, protection was believed to last for 10 years. New data show that protection lasts only 5 years. This means that meningococcal vaccination at age 11 years does not provide lasting immunity through high-risk years, including those spent living in a college dormitory (9). The new recommendation adds a booster at age 16 years in addition to initial vaccination at age 11 to 12 years, which is an off-label use of the vaccine. The decision to recommend a 2-dose regimen was heavily influenced by the deadly and devastating nature of meningococcal infection. Although this 2-dose regimen is one of the most expensive vaccine regimens currently recommended, it is also expected to prevent the greatest number of cases of meningococcal disease (10, 11).

Final Thoughts: Get Vaccinated!

Universal influenza vaccination includes health care workers—all of us. In the past year, the American Medical Association (12), the Society for Healthcare Epidemiology of America with endorsement by the Infectious Diseases Society of America (13), the American Academy of Pediatrics (14), and the ACP (15) have strengthened their existing policies on influenza vaccination for health care workers. New ACP policy declares that “health care workers who cannot receive flu vaccines due to medical or religious contraindications should either be reassigned to non–patient care areas during influenza season or wear a mask at all times during influenza season in the context of patient care.” Influenza vaccination of health care workers is undoubtedly a patient safety issue. We must each do our part to reach the goal of 100% flu vaccination. Get vaccinated today!
Note added in proof: The HPV4 vaccine received FDA approval on 22 December 2010 for anal cancer prevention in males and females aged 9 to 26 years.

References

  1. Advisory Committee on Immunization Practices
    Recommended adult immunization schedule: United States, 2011.
    Ann Intern Med
    2011
    154
    168
    73
  2. Recommended immunization schedules for persons aged 0-18 years—United States, 2011. MMWR. 2011. [Forthcoming].
  3. Centers for Disease Control and Prevention (CDC)
    Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep
    2007
    56
    1
    24
     PubMed
  4. Gillison
    ML
    ,  
    Chaturvedi
    AK
    ,  
    Lowy
    DR
    .  
    HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
    Cancer
    2008
    113
    3036
    46
     PubMed
    CrossRef
  5. Watson
    M
    ,  
    Saraiya
    M
    ,  
    Ahmed
    F
    ,  
    Cardinez
    CJ
    ,  
    Reichman
    ME
    ,  
    Weir
    HK
    .  et al. 
    Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
    Cancer
    2008
    113
    2841
    54
     PubMed
  6. Joseph
    DA
    ,  
    Miller
    JW
    ,  
    Wu
    X
    ,  
    Chen
    VW
    ,  
    Morris
    CR
    ,  
    Goodman
    MT
    .  et al. 
    Understanding the burden of human papillomavirus-associated anal cancers in the US.
    Cancer
    2008
    113
    2892
    900
     PubMed
  7. Wendelboe
    AM
    ,  
    Njamkepo
    E
    ,  
    Bouvillon
    A
    ,  
    Floret
    DD
    ,  
    Gaudelus
    J
    ,  
    Gerber
    M
    .  et al. 
    Infant Pertussis Study Group
    Transmission of Bordetella pertussis to young infants.
    Pediatr Infect Dis J
    2007
    26
    293
    9
     PubMed
  8. Bisgard
    KM
    ,  
    Pascual
    FB
    ,  
    Ehresmann
    KR
    ,  
    Miller
    CA
    ,  
    Cianfrini
    C
    ,  
    Jennings
    CE
    .  et al. 
    Infant pertussis: who was the source?
    Pediatr Infect Dis J
    2004
    23
    985
    9
     PubMed
  9. Cohn A. Rationale and proposed recommendations for two dose primary vaccination for persons at increased risk for meningococcal disease. Presented at a meeting of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Atlanta, Georgia, 23 June 2010. Accessed atwww.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-oct10/02-2-mening-highrisk.pdfon 18 November 2010.
  10. Ortega-Sanchez
    IR
    ,  
    Lee
    GM
    ,  
    Jacobs
    RJ
    ,  
    Prosser
    LA
    ,  
    Molinari
    ,  
    Zhang
    X
    .  et al. 
    Working Group on Leading Economic Issues for New Vaccine for Adolescents
    Projected cost-effectiveness of new vaccines for adolescents in the United States.
    Pediatrics
    2008
    121
    Suppl 1
    S63
    78
     PubMed
  11. Ortega-Sanchez I. Cost-effectiveness of meningococcal vaccination strategies for adolescents in the United States. Presented at a meeting of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Atlanta, Georgia, 27 October 2010. Accessed atwww.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-oct10/02-3-mening-CostEffect.pdfon 18 November 2010.
  12. American Medical Association. Reports of the Council on Ethical and Judicial Affairs. CEJA Report 5-I-10. Routine universal immunization of physicians for vaccine-preventable disease (resolution 922-I-09 and 928-I-09). Accessed atwww.ama-assn.org/ama1/pub/upload/mm/2010i/addendum-ref-comm-candb.pdfon 18 November 2010.
  13. Talbot
    TR
    ,  
    Babcock
    H
    ,  
    Caplan
    AL
    ,  
    Cotton
    D
    ,  
    Maragakis
    LL
    ,  
    Poland
    GA
    .  et al. 
    Revised SHEA position paper: influenza vaccination of healthcare personnel.
    Infect Control Hosp Epidemiol
    2010
    31
    987
    95
     PubMed
  14. Bernstein
    HH
    ,  
    Starke
    JR
    .  
    American Academy of Pediatrics
    Committee on Infectious Diseases
    Policy statement—recommendation for mandatory influenza immunization of all health care personnel.
    Pediatrics
    2010
    126
    809
    15
     PubMed
  15. American College of Physicians. ACP policy on influenza vaccination of health care workers. Accessed atwww.acponline.org/clinical_information/resources/adult_immunization/flu_policy_hcw.pdfon 18 November 2010.

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Fryhofer SA. Immunization 2011: Expanding Coverage, Enhancing Protection. Ann Intern Med. 2011;154:204–206. doi: https://doi.org/10.7326/0003-4819-154-3-201102010-00011

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2019

×
Permissions

Published: Ann Intern Med. 2011;154(3):204-206.

DOI: 10.7326/0003-4819-154-3-201102010-00011

0 Citations

See Also

Recommended Adult Immunization Schedule: United States, 2011
View MoreView Less

Related Articles

Diphtheria, Tetanus, and Pertussis: Guidelines for Vaccine Prophylaxis and Other Preventive Measures: Recommendation of the Immunization Practices Advisory Committee
Annals of Internal Medicine; 103 (6_Part_1): 896-905
Annals for Educators - 20 December 2016
Annals of Internal Medicine; 165 (12): ED12
Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial
Annals of Internal Medicine; 165 (9): 617-624
Recommended Adult Immunization Schedule: United States, 2013*
Annals of Internal Medicine; 158 (3): 191-199
View MoreView Less

Journal Club

In older adults, high- vs standard-dose influenza vaccine reduced laboratory-confirmed influenza
Annals of Internal Medicine; 162 (2): JC2
Review: Influenza vaccine reduces influenza-like illness in healthy adults
Annals of Internal Medicine; 161 (6): JC6
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines
Annals of Internal Medicine; 162 (12): JC8
HPV vaccination reduced cytologic abnormalities compared with control vaccination in young women
Annals of Internal Medicine; 159 (12): JC4
View MoreView Less

Related Point of Care

Travel Medicine
Annals of Internal Medicine; 168 (1): ITC1-ITC16
Travel Medicine
Annals of Internal Medicine; 156 (11): ITC6-1
Influenza
Annals of Internal Medicine; 147 (7): ITC10-1
View MoreView Less

Related Topics

Infectious Disease
Prevention/Screening
Vaccines/Immunization

Infectious Disease, Prevention/Screening, Vaccines/Immunization.

CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×